Gilles Picard

Gilles Picard has an extensive work experience in the pharmaceutical industry. Gilles has held various leadership roles in notable companies such as Indivior, KOWA Company, AbbVie, and Schering-Plough. At Indivior, Gilles currently serves as the President of US Addiction Sciences. Gilles previously served as the SVP of Europe, Canada, and MEA operations, where they successfully launched new drugs, implemented a lifecycle management strategy, and achieved certification for all Europe and Canada affiliates as a "Great Place to Work". Prior to Indivior, they were the President of Europe & MEA at KOWA Company, responsible for commercial and clinical operations. Gilles also served as the VP of Asia-Pacific & Middle East Africa at AbbVie, where they led the Abbott Pharma Division and doubled Abbvie's business in the Asia-Pacific region. Before AbbVie, they held the position of President of Schering-Plough France, and prior to that, they were the Regional VP of Europe at Schering-Plough. Overall, Gilles Picard has a strong track record of improving profitability, implementing resource allocation strategies, and driving business growth in the pharmaceutical industry.

Gilles Picard has completed a Sr Executive Program in Business from the London Business School. Gilles has also obtained a Master's degree in Biotechnology from the National Institute of Agronomy, Paris, France. Additionally, Gilles holds a DVM (Doctor in Veterinary Medicine) from the National Veterinary School in Lyon, France.